Probe Handling And Infection Control - GE LOGIQ E9 User Manual

Hide thumbs Also See for LOGIQ E9:
Table of Contents

Advertisement

Probe handling and infection control

CAUTION
CAUTION
CAUTION
LOGIQ E9
User Guide
Direction 5454884-100 English Rev. 1
This information is intended to increase user awareness of the
risks of disease transmission associated with using this
equipment and provide guidance in making decisions directly
affecting the safety of the patient as well as the equipment user.
Diagnostic ultrasound systems utilize ultrasound energy that
must be coupled to the patient by direct physical contact.
Depending on the type of examination, this contact occurs with a
variety of tissues ranging from intact skin in a routine exam to
recirculating blood in a surgical procedure. The level of risk of
infection varies greatly with the type of contact.
One of the most effective ways to prevent transmission between
patients is with single use or disposable devices. However,
ultrasound transducers are complex and expensive devices that
must be reused between patients. It is very important, therefore,
to minimize the risk of disease transmission by using barriers
and through proper processing between patients.
Risk of Infection. ALWAYS clean and disinfect the probe
between patients to the level appropriate for the type of
examination and use FDA-cleared probe sheaths where
appropriate.
Adequate cleaning and disinfection are necessary to prevent
disease transmission. It is the responsibility of the equipment
user to verify and maintain the effectiveness of the infection
control procedures in use. Always use sterile, legally marketed
probe sheaths for intra-cavitary and intra-operative procedures.
For neurological intra-operative procedures, use of a legally
marketed, sterile, pyrogen free probe sheath is REQUIRED.
Probes for neuro surgical use must not be sterilized with liquid
chemical sterilants because of the possibility of neuro toxic
residues remaining on the probe.
Devices containing latex may cause severe allergic reaction in
latex sensitive individuals. Refer to FDA's March 29, 1991
Medical Alert on latex products.
Probe Overview
3-3

Advertisement

Table of Contents
loading

Table of Contents